Lotem Michal M,D,

Education / Training

2002-2004  Research fellow, Surgery Branch, NCI, NIH,Bethesda MD

1993-1995  Resident, Department of Oncology, Beilinson Medical Center, Petah Tiqva, Israel

1986-1993  Resident, Department of Dermatology, Beilinson Medical Center, Petah Tiqva, Israel

1982-1983, Internship in Medicine, AssafHarofeh Medical Center, Zerifin, Israel

1976-1983 MD, Sackler School of Medicine, Tel Aviv University, Israel

Appointments

Head of the Center for Melanoma and Cancer Immunotherapy, Dept. of Oncology, Board member in the ministry of health committee for genetic and cytologic treatment

1995-2002  Senior Physician, Department of Dermatology, Hadassah University Hospital, EinKarem, Jerusalem, Israel

2000 - Lecturer in Dermatology and Oncology, Faculty of Medicine, Hebrew University, Israel

1997-Present  Senior Physician, Sharett Institute of Oncology, Hadassah University Hospital, EinKarem, Jerusalem, Israel

1997 - Instructor in Dermatology, Faculty of Medicine,Hebrew University, Israel

Awards / Grants

2015 Michal Lotem has been awarded a grant from the prestigious Melanoma Research Alliance (MRA).The grant, for $337,500 over three years, was given to the Hadassah team, including Dr. Galit Eisenberg and Dr. RoniEngelstein, to find the best method of treating melanoma under lab conditions and to identify a medication that will prove effective against the disease in patients.

2006-2007  Supporting organization: The Horowitz Foundation/  Title of research project: Membrane capture by antigen-specific T cells – a method to detect and isolate anti-tumor cytotoxic lymphocytes. 62,000$.  Role: PI

2005 - Supporting organization: Chief Scientist Israeli Ministry of Health.  Title of research project: Immunological evaluation of melanoma patients treated by autologous melanoma cell vaccine: Quantitative and qualitative analysis. $15,000.  Role: PI

2001-2003  Supporting organization: Cancer Treatment Research Foundation. Title of research project: Phase I/II study of dendritic cell vaccine with liposomal IL-2 for metastatic melanoma.  Role: PI

2001-2002  Supporting organization: Israel Cancer Association.  Title of research project: Treatment of Kaposi  sarcoma with ganciclovir and characterization of virological markers for monitoring the disease.  Role: PI

2000-2001  Supporting organization: The Horowitz Foundation Grant.  Title of research project: Development of a vaccine for metastatic melanoma using specific antigen-pulsed dendritic cells.  Role: PI

1999-2000  Supporting organization: The Horowitz Foundation Grant.  Title of research project: Development of a vaccine for metastatic melanoma using specific antigen-pulsed dendritic cells (DC) with and without liposome-encapsulated GM-CSF.  Role: PI

1999-2000  Supporting organization: Israel Cancer Association  Title of research project: Development of a vaccine for metastatic melanoma using specific antigen-pulsed dendritic cells (DC) with and without liposome-encapsulated GM-CSF.  Role: PI